Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ferchal

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Archives of Dermatology|March 1, 1996
Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2bC S Costa da Cunha, C Lebbe, M Rybojad, et al.
Journal of Virological Methods|May 1, 1992
HIV-1 sensitivity to zidovudine: a consensus culture technique validated by genotypic analysis of the reverse transcriptaseF Brun-Vézinet, D Ingrand, L Deforges, et al.
Antiviral Therapy|July 19, 2005
Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patientsJ M Molina, G Chêuc, F Ferchal, et al.
The Journal of Infectious Diseases|July 9, 1999
The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virusJ M Molina, G Chêne, F Ferchal, et al.
Antiviral Therapy|February 22, 2000
Stavudine resistance: an update on susceptibility following prolonged therapyP F Lin, C J González, B Griffith, et al.
Antiviral Therapy|February 22, 2000
Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the delta lamivudine roll-over studyB Masquelier, D Descamps, I Carrière, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Archives of Dermatology|March 1, 1996
Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2bC S Costa da Cunha, C Lebbe, M Rybojad, et al.
Journal of Virological Methods|May 1, 1992
HIV-1 sensitivity to zidovudine: a consensus culture technique validated by genotypic analysis of the reverse transcriptaseF Brun-Vézinet, D Ingrand, L Deforges, et al.
Antiviral Therapy|July 19, 2005
Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patientsJ M Molina, G Chêuc, F Ferchal, et al.
The Journal of Infectious Diseases|July 9, 1999
The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virusJ M Molina, G Chêne, F Ferchal, et al.
Antiviral Therapy|February 22, 2000
Stavudine resistance: an update on susceptibility following prolonged therapyP F Lin, C J González, B Griffith, et al.
Antiviral Therapy|February 22, 2000
Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the delta lamivudine roll-over studyB Masquelier, D Descamps, I Carrière, et al.
Pageof 7